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Objective: Despite the frequent occurrence of depressive symptoms in obsessive-compulsive disorder
(OCD), little is known about the reciprocal inﬂuence between depressive and obsessive-compulsive
symptoms during the course of the disease. The aim of the present study is to investigate the longitudinal
relationship between obsessive-compulsive and depressive symptoms in OCD patients.
Method: We used the baseline and 1-year follow-up data of the Netherlands Obsessive Compulsive
Disorder Association (NOCDA) study. In 276 patients with a lifetime diagnosis of obsessive-compulsive
disorder, depressive and obsessive-compulsive symptoms were assessed at baseline and at one-year
follow-up with the Beck Depression Inventory (BDI) and the Yale-Brown Obsessive Compulsive Symptom
(Y-BOCS) scale. Relations were investigated using a cross-lagged panel design.
Results: The association between the severity of depressive symptoms at baseline and obsessive-com-
pulsive symptoms at follow-up was signiﬁcant (β¼0.244, po0.001), while the association between the
severity of obsessive-compulsive symptoms at baseline and depressive symptoms at follow-up was not
(β¼0.097, p¼0.060). Replication of the analyses in subgroups with and without current comorbid major
depressive disorder (MDD) and subgroups with different sequence of onset (primary versus secondary
MDD) revealed the same results.
Limitations: There may be other factors, which affect both depressive and obsessive-compulsive symp-
toms that were not assessed in the present study.
Conclusion: The present study demonstrates a relation between depressive symptoms and the course of
obsessive-compulsive symptoms in OCD patients, irrespective of a current diagnosis of MDD and the
sequence of onset of OCD and MDD.
& 2016 Elsevier B.V. All rights reserved.1. Introduction
Obsessive-compulsive disorder (OCD) is a disabling and often
chronic psychiatric disorder which leads to signiﬁcant impairment5600 AX Eindhoven, The
y.nl (J. Rickelt).in daily life and diminished well-being (Farris et al., 2013; Hol-
lander et al., 2010; Albert et al., 2010; Eisen et al., 2006). About
0.5–3% of the general population develops OCD in their lifetime
(Grabe et al., 2001; Kessler et al., 2012; Subramaniam et al., 2012).
Comorbidity is the rule rather than the exception, with major
depressive disorder (MDD) being one of the most frequent co-
morbid diagnoses (Lochner et al., 2014; Klein Hofmeijer-Sevink
et al., 2013). Comorbidity rates differ largely due to methodological
differences, but overall approximately one third of the patients
J. Rickelt et al. / Journal of Affective Disorders 203 (2016) 241–247242with OCD suffer from a current comorbid MDD, and about two-
third have lifetime comorbidity of MDD (Viswanath et al., 2012;
Quarantini et al., 2011; Torres et al., 2006; Pinto et al., 2006; La-
Salle et al., 2004). Moreover, many OCD patients suffer from de-
pressive symptoms, but do not fulﬁll the diagnostic criteria for a
depressive episode.
Depressive symptoms often are regarded as a consequence of
the burden of OCD. OCD is associated with a decreased quality of
life and an increased functional impairment in work, family and
social life (Huppert et al., 2009). OCD patients spend more time
thinking of the obsessions and performing compulsions, accom-
panied by anxiety, and thus experience less positive activities and
emotions, which may lead to depressive symptoms. However, al-
though several studies found a correlation between depressive
symptoms and diminished quality of life as well as functional
impairment, depressive symptoms appeared to be rather a med-
iating factor between the severity of the obsessive-compulsive
symptoms and these factors than a consequence of them (Kugler
et al., 2013; Storch et al., 2014).
Several studies found evidence for common genetic factors of
obsessive-compulsive and depressive symptoms. MDD occurs
more often in ﬁrst-degree relatives of OCD patients compared to
relatives of healthy controls and vice versa, which demonstrates
the familial aggregation of this comorbidity (Carter et al., 2004;
Goes et al.; 2012). In addition, Bolhuis et al. found that the co-
occurrence of obsessive-compulsive and depressive symptoms is
mainly explained by shared genetic factors while the contribution
of non-shared environmental factors is considerably smaller
(Bolhuis et al., 2014).
Despite the frequent occurrence of comorbid obsessive-com-
pulsive and depressive symptoms, the treatment of comorbid de-
pression in OCD is still a matter of debate. Some authors suggest to
address also the depressive symptomatology while treating OCD
(Olatunji et al., 2013; Abramowitz 2004; Rector et al., 2009),
whereas others expect the depressive symptoms to improve along
with the obsessive-compulsive symptoms, and recommend to fo-
cus on the treatment of the OCD only, without speciﬁc interven-
tions addressing the depression (Anholt et al., 2011; Zandberg
et al., 2015; Zitterl et al., 2000).
Further knowledge about the relationship between obsessive-
compulsive and depressive symptoms may help to solve this de-
bate. Most cross-sectional studies found a correlation between
obsessive-compulsive and depressive symptoms in OCD patients
(Besiroglu et al., 2007; Abramowitz and Foa, 2000; Demal et al.,
1996) but no conclusions about the direction of this relationship
can be drawn from correlational analyses alone. To that end, ob-
sessive-compulsive and depressive symptoms have to be studied
over time.
The present study aims to investigate the longitudinal re-
lationship between obsessive-compulsive and depressive symp-
toms in OCD patients during the disease course. First, we studied
the inﬂuence of comorbid depression on the severity and the
course of OCD. We hypothesized that comorbid depression is as-
sociated with more severe obsessive-compulsive symptoms and a
worse course. Second, we investigated the direction of the long-
itudinal relationship between obsessive-compulsive and depres-
sive symptoms, to examine whether obsessive-compulsive symp-
toms lead to depressive symptoms or vice versa. Based on the
literature, we expected a reciprocal inﬂuence with a greater im-
pact of obsessive-compulsive symptoms on the depressive symp-
toms than vice versa. Third, we studied whether the relationship
between obsessive-compulsive and depressive symptoms differs
between patients with and without a diagnosis of current MDD,
and between patients who ﬁrst had MDD and developed OCD later
in life (primary depression) and those who developed MDD during
the course of the OCD (secondary depression). We hypothesized agreater inﬂuence of depressive symptoms on the obsessive-com-
pulsive symptoms in OCD patients with a comorbid depression
and in patients with primary MDD.2. Methods
2.1. Participants
Data were obtained from the NOCDA study (Schuurmans et al.,
2012). The NOCDA study is an ongoing longitudinal naturalistic
multicenter cohort study which examines the course of OCD in 419
OCD patients. Patients were included between September 2005
and November 2009 at one of seven participating mental health
care centers in the Netherlands. All referred patients aged 18 years
and older with a lifetime diagnosis of OCD were asked for per-
mission to be contacted for research purposes, irrespective of the
stage of the disease, the severity of the obsessive-compulsive
symptoms and comorbid diagnoses. The only exclusion criterion
was an inadequate understanding of the Dutch language for the
completion of the interviews and questionnaires.
Six hundred eighty-seven patients with OCD were invited to
participate in the study. Ninety-seven subjects (28.7%) refused tot
participate, 32 subjects (4.7%) were not able to participate due to
mental or physical health problems and 39 (5.7%) subjects could
not be contacted. Subjects who participated in the study and eli-
gible patients who chose not to participate did not differ regarding
sex, age or years of education (Schuurmans et al., 2012). At one of
the participating centers (Academic Anxiety Center, PsyQ Maas-
tricht) the subjects who participated in the NOCDA study were
compared to those who did not participate regarding clinical
characteristics, yielding no signiﬁcant differences (results not
published).
All included patients gave written informed consent to parti-
cipate. The study is approved by the Medical Ethical Committee
VUmc (Amsterdam) and the local Medical Ethical Committees of
all participating centers.
The present study is based on the data from the semi-struc-
tured interviews and the self-administered questionnaires of the
baseline measurement and the self-administered questionnaires of
the follow-up after one year.
2.2. Measures
At baseline, we used the Structured Clinical Interview for the
DSM-IV-TR (SCID-I/P) to assess the axis-I morbidity (First et al.,
1999). Among others, current and lifetime OCD as well as current
and lifetime MDD were diagnosed according to the criteria of the
DSM-IV-TR (APA, 2000). We assessed retrospectively the age of
onset of the OCD and the MDD using the SCID-I/P. Age of onset was
deﬁned by the age of the participant when the DSM-IV-TR criteria
of OCD and MDD were ﬁrst met. If the onset of the lifetime di-
agnosis of MDD preceded the onset of lifetime diagnosis of OCD,
we deﬁned it as primary depression. If the lifetime onset of the
MDD succeeded the onset of the OCD, we deﬁned it as secondary
depression. If the criteria of OCD and MDD were met at the same
age, we considered it as simultaneous onset.
The severity of obsessive-compulsive symptoms was measured
at baseline using the clinician rated Yale-Brown Obsessive Com-
pulsive Symptom (Y-BOCS) severity scale (Goodman et al., 1989a,
1989b) and at one-year follow-up using the self-rate version of the
Y-BOCS (Steketee et al., 1996). The severity of depressive symp-
toms was measured at baseline and at one-year follow-up by the
Beck Depression Inventory (BDI, Beck et al., 1961).
t0 t1 
BDI BDI 
Y-BOCS Y-BOCS 
Fig. 1. Cross-lagged panel design. Regression Y-BOCS t0 – BDI t1, corrected
for BDI t0, leading tot regression coefﬁcient beta βY-BOCS t0 – BDI t1. Regression
BDI t0 – Y-BOCS t1, corrected for Y-BOCS t0, leading tot regression coefﬁcient beta
β BDI t0 – Y-BOCS t1.
Table 1
Characteristics of the sample at baseline and 1-year follow-up.
Baseline (n¼419) Follow-up (n¼286)
Mean age 37 years (18–79) 38 years (19–80)
Male n¼185 (44.2%) n¼119 (41.6%)
Female n¼234 (55.8%) n¼167 (58.4%)
OCD at baseline current n¼382 (91.2%) n¼257 (89.9%)
OCD at baseline lifetime n¼419 (100%) n¼286 (100%)
Comorbidity at baseline
Any current comorbidity n¼223 (53.2%) n¼163 (57%)
Any lifetime comorbidity n¼326 (77.8%) n¼227 (79.4%)
Major depressive disorder at base-
line current
n¼72 (17.2%) n¼50 (17.5%)
Major depressive disorder at base-
line lifetime
n¼237 (56.6%) n¼168 (58.7%)
Other comorbid diagnoses at base-
line (current)
Dysthymic disorder n¼22 (5.3%) n¼12 (4.2%)
Bipolar disorder n¼4 (1%) n¼3 (1%)
Social phobia n¼75 (17.9%) n¼57 (19.9%)
Panic Disorder with/ without n¼13 (3.1%) n¼27 (9.4)
agoraphobia
Agoraphobia without panic n¼7 (1.7%) n¼4 (1.4%)
disorder
Generalized anxiety disorder n¼38 (9.1%) n¼30 (10.5)
Posttraumatic stress disorder n¼13 (3.1%) n¼11 (3.8)
Speciﬁc phobia n¼35 (8.4%) n¼27 (9.4%)
Anxiety disorder not otherwise n¼2 (0.5%) n¼2 (0.7)
speciﬁed
Any psychotic disorder (incl. n¼10 (2.4%) n¼5 (1.7)
schizophrenia)
Substance related disorders n¼20 (4.8%) n¼11 (3.8%)
Somatoform disorders n¼22 (5.3%) n¼18 (6.3%)
Eating disorders n¼19 (4.5%) n¼17 (5.9%)
Measures
YBOCS mean 20 (0–40, SD 8.1) 15.9 (0–40, SD 8.8)
BDI mean 15.3 (0–51, SD
10.1)
12.6 (0–56, SD 10.6)
Treatment
Current antidepressant n¼257 (61.3%) n¼172 (60.1%)
medication
Any contact with mental in the last
6 months
in the last 12 months
health care professionals n¼348 (83.1%) n¼263 (92%)
mean¼9
sessions
mean¼16.3 sessions
(0–150, SD 12.1) (0–260, SD 26)
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Independent samples t-test were used to test for differences
between participants with and without comorbid MDD at baseline
with respect to their Y-BOCS scores at t0 and t1. Analyses to test
for differences in the baseline characteristics of participants who
dropped-out versus those who continued their participation were
performed using Pearson chi square tests for sex, current/lifetime
diagnoses and antidepressants medication, a Mann-Whitney U test
for age, and independent samples t-tests for Y-BOCS scores, BDI
scores and frequency of contacts with mental health care profes-
sionals. The differences between the treatment of participants
with and without a comorbid MDD were performed using Pearson
chi square tests (antidepressant medication, any contact with
mental health care professionals in the last 12 months) and in-
dependent samples t-test (frequency of contacts with mental
health care professionals in the last 12 months).
To examine the direction of the relation between obsessive-
compulsive symptoms and the depressive symptoms, we used a
cross-lagged panel (CLP) analysis. After standardizing the Y-BOCS
and BDI variables, we ﬁtted the path model shown in Fig. 1, where
the Y-BOCS and BDI scores at follow-up (t1) are regressed on the
scores at baseline (t0) simultaneously. Of particular interest here
are the cross-lagged paths (i.e., Y-BOCS t0-BDI t1 and BDI t0-Y-
BOCS t1) that provide evidence about the direction of the re-
lationship between two variables (e.g., when one coefﬁcient is
large and signiﬁcant and the other is not). Moreover, we directly
tested whether the strength of the cross-lagged coefﬁcients dif-
fered by ﬁtting a path model with the cross-lagged paths con-
strained to be equal and compared this to the unconstrained
model using a chi-square test with one degree of freedom. The
path models were ﬁtted using maximum likelihood (ML) estima-
tion. To examine whether this relation differs between partici-
pants with and without a current MDD at baseline, we repeated
these analyses for these subgroups. We also performed a CLP
analysis with the subgroups of patients in which the depressive
disorder preceded the obsessive-compulsive disorder (primary
depression) and those in which the onset of MDD succeeded the
onset of OCD (secondary depression) to examine whether the di-
rection of the relation between obsessive-compulsive and de-
pressive symptoms differs between these groups.
If 20% or more of the items were missing for a particular scale
for a given subject (i.e., 2 or more items on the Y-BOCS and/or 4 or
more items on the BDI), the data were considered unreliable and
the subject was excluded from the analysis. If fewer items were
missing, we left the scale total as missing and then ﬁtted the path
models using full information maximum likelihood (FIML). Ana-
lyses were carried out with SPSS (version 20) and R (version 3.2.2),
using the lavaan package for the path analyses (Rosseel, 2012).3. Results
3.1. Clinical characteristics
Demographic and clinical characteristics of the sample are
shown in Table 1. At baseline, 419 participants were included. At
follow-up after one year, 133 participants (31.7%) dropped out,
leaving 286 participants. There were no signiﬁcant differences at
baseline between participants who dropped out and participants
who continued participation regarding age, sex, current and life-
time diagnosis of OCD, current and lifetime diagnosis of MDD,
other comorbidities, severity of obsessive-compulsive symptoms,
severity of depressive symptoms, antidepressant medication and
previous contacts with mental health care professionals.
At baseline, 72 participants (17.2%) had a current MDD. Within
the group that participated in the follow-up, 50 participants
(17.5%) had a current MDD at baseline. There was no difference in
the use of antidepressant medication, contact with a mental health
care professional in the last 12 months and the frequency of
contacts with a mental health care professional in the last 12
months between participants with and without a comorbid MDD.
Baseline Y-BOCS and BDI total scores were available for 414 and
398 participants, respectively, and for 283 participants at follow-
up. Thirty-four percent of the participants (n¼143) were excluded
0 70 
Age of onset
in years
21 (SD 9.6) 4 59 
6 58 
28 (SD 10.4) 
46 4 
16 (SD 9.5) 
7 42 
19 (SD 8.8) 
26 (SD 9.8) 
10 46 
18 (SD 10.5)  
26 (SD 11)  
4 
4 
59 
59 All lifetime 
OCD + MDD 
Primary MDD 
n= 30 
Secondary MDD 
n= 134 
Age of onset 
OCD = MDD 
n= 24 
Fig. 2. Sequence of age of onset of OCD and MDD. Age of onset OCD
with mean age of onset. Age of onset MDD with mean age of onset.
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at baseline or follow-up due to drop out (n¼133) or incomplete
questionnaires (n¼10), leaving 276 participants.
3.2. Temporal sequencing
The age of onset of OCD and MDD was available in 377 of the
419 participants with lifetime OCD and in 207 of the 237 partici-
pants with lifetime MDD. The mean age of onset of OCD was 18
years (range 4-59 years, SD 9.6), and the mean age of onset of
MDD was 26 years (range 4-59, SD 9.6). Of the participants with
comorbid lifetime MDD (n¼237), the age of onset of both OCD and
MDD was available in 188 participants (79.3%). In 30 participants
(16%) MDD preceded OCD (primary MDD), in 134 participants
(71%) OCD preceded MDD (secondary MDD), and in 24 partici-
pants (13%) MDD and OCD occurred at the same age. The sequence
and age of onset are shown in Fig. 2.
For the CLP analyses of the groups of primary and secondary
depression, the Y-BOCS and BDI at both baseline and 1-year fol-
low-up were available in 127 participants with known age of onset
of OCD and MDD. Eighteen participants (14.2%) had a primary
MDD, 94 participants (74%) had a secondary MDD, and in 15 par-
ticipants (11.8%) OCD and MDD had the onset at the same age.
3.3. Comorbid major depressive disorder
To examine the relationship between current Major Depressive
Disorder (MDD) at baseline and the severity of the obsessive-
compulsive symptoms at baseline and follow-up, we compared
the mean Y-BOCS score of the depressed participants with the
mean Y–BOCS score of the non-depressed participants.
In the group with a current comorbid MDD, the mean Y-BOCS
score at baseline was 24.5 (SD 7.6). Non-depressed participants
had a mean baseline Y-BOCS score of 18.9 (SD 7.9). This difference
was statistically signiﬁcant (po0.001). Participants with current
MDD at baseline also had a signiﬁcantly higher mean score on theTable 2
Regression coefﬁcients per subgroup.
Y-BOCS t0 – BDI t1 BDI t0
Β p β
All participants (n¼276) β¼0.097 p¼0.060 β¼0.24
Current MDD (n¼50) β¼0.127 p¼0.275 β¼0.46
No current MDD (n¼226) β¼0.099 p¼0.098 β¼0.19
Primary MDD (n¼18) β¼0.036 p¼0.877 β¼0.71
Secondary MDD (n¼94) β¼0.154 p¼0.093 β¼0.26
* Signiﬁcant at po0.05,
** Signiﬁcant at po0.01.Y-BOCS severity scale at the one-year follow-up assessment, that
is, 18.7 (SD 10.4) versus 15.4 (SD 8.4), respectively (p¼0.017).
3.4. Relation between obsessive-compulsive and depressive
symptoms
To examine the relation between obsessive-compulsive and
depressive symptoms, we performed the CLP analysis for the
whole group and different subgroups. The results are shown in
Table 2.
In all analyses, the relationship between BDI at baseline and
Y-BOCS at follow-up was signiﬁcant, while the association be-
tween the Y-BOCS score at baseline and the BDI score at follow-up
was not.
When we compared the strength of both regression paths di-
rectly, they did not differ signiﬁcantly, except in the group of
primary MDD. In this subgroup, the depressive symptoms had a
signiﬁcantly stronger effect on the obsessive-compulsive symp-
toms than vice versa.4. Discussion
In the present longitudinal study we investigated major de-
pressive disorder (MDD) and depressive symptoms in obsessive-
compulsive disorder (OCD), using data from the NOCDA study
which to our knowledge is the largest longitudinal cohort study in
OCD. We found a signiﬁcant association between the severity of
depressive symptoms at baseline and obsessive-compulsive
symptoms one year later, while the relation between the severity
of obsessive-compulsive symptoms at baseline and depressive
symptoms at follow-up was not signiﬁcant. This effect was ob-
served in all groups, irrespective of a comorbid MDD or whether
the MDD preceded or succeeded the OCD.
There are a few prospective longitudinal studies, which address
the direction of the relation between obsessive-compulsive and
depressive symptoms. A twin study in adolescents with OCD in-
vestigated the longitudinal relationship between obsessive-com-
pulsive and depressive symptoms. They concluded that obsessive-
compulsive symptoms predict depressive symptoms two years
later to a similar extent to which depressive symptoms predict
obsessive-compulsive symptoms. There are several methodologi-
cal differences that may account for the partially different results.
The participants were adolescent twins, the obsessive-compulsive
symptoms and depressive symptoms were measured by the
Spence Children's Anxiety Scale and the Short Mood and Feelings
Questionnaire, and the study period was two years. In addition,
the study was designed as a twin study with the primary aim to
investigate the inﬂuence of genetic versus environmental factors
on the comorbidity of OCD and MDD (Bolhuis et al., 2014).
A treatment study which investigated the mediators of change
in behavioral versus cognitive therapy in OCD patients found that– Y-BOCS t1 Test of βY-BOCS t0-BDI t1¼βBDI t0-Y-BOCS t1
P
4 po0.001** p¼0.084
6 p¼0.001** p¼0.083
1 p¼0.003** p¼0.328
9 po0.001** p¼0.034*
1 p¼0.014* p¼0.504
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tom severity in both behavioral and cognitive therapy (Olatunji
et al., 2013). Other research contradicts this conclusion. Anholt
et al. (2011) investigated the relation between obsessive-compul-
sive and depressive symptoms in patients following different
treatment conditions speciﬁc for OCD. This study was recently
replicated for exposure with response prevention in combination
with a serotonergic reuptake inhibitor (Zandberg et al., 2015). Both
studies found that obsessive-compulsive symptoms fully mediated
changes in depressive symptoms while depressive symptoms only
partially mediated OCD symptoms. The studies differ from our
study in several aspects. They included patients with clinical
symptoms of OCD with a higher mean Y-BOCS severity score for
different therapeutic interventions. In contrast, our study used a
naturalistic design and included OCD patients irrespective of the
state or severity of the OCD leading to a greater range of OCD
symptom severity. Both clinical trials had more stringent inclusion
criteria and excluded certain comorbidities, while the present
study did not.
In the present study, the comorbid diagnosis of MDD was as-
sociated with more severe obsessive-compulsive symptoms at the
same time as well as one year later. This is in line with several
cross-sectional studies that reported more severe obsessive-com-
pulsive symptoms in OCD patients with comorbid MDD (Demal
et al., 1996; Viswanath et al., 2012; Quarantini et al., 2011; Karadag
et al., 2006;Tükel et al., 2006) although no conclusion regarding
the prognostic impact of comorbid MDD can be drawn based on
these ﬁndings. In a 15-year prospective follow-up study on the
course of OCD, Marcks et al. (2011) found that MDD at intake was
associated with a decreased likelihood of recovery and remission
of OCD.
Because of the reported signiﬁcant effect of MDD on the se-
verity of the OCD symptoms during the course of the disease, we
investigated whether the effect of depressive symptoms on the
disease course could be explained by the group of patients with a
current comorbid MDD at baseline. Our results show that this was
not the case: the depressive symptoms were associated with the
course of the obsessive-compulsive symptoms as well in OCD
patients with MDD as in OCD patients without MDD.
Some authors suggest that the sequence of onset of OCD and
MDD may inﬂuence the direction of the relation between both
disorders, expecting that obsessive-compulsive symptoms have a
greater inﬂuence on comorbid depressive symptoms when the
depression developed after the onset of OCD (Zandberg et al.,
2015; Zitterl et al., 2000; Besiroglu et al., 2007). Several clinical
studies found that MDD succeeded the OCD in the majority of
cases (Subramaniam et al., 2012; Zitterl et al., 2000; Ruscio et al.,
2010; Millet et al., 2004). Also in the present study, seventy-one
percent of the patients ﬁrst suffered from OCD and developed
MDD later in life. In the small group with primary MDD, the de-
pressive symptoms had a signiﬁcant stronger effect on the ob-
sessive-compulsive symptoms than vice versa. But also in the
group which developed MDD during the course of OCD, we found
a signiﬁcant relation between depressive symptoms at baseline
and obsessive-compulsive symptoms at follow-up while the op-
posite association was not signiﬁcant.
These results suggest that the direction of the relation is not
inﬂuenced by the sequence of onset. However, both OCD and MDD
often have a ﬂuctuating course with variations in the severity of
symptoms and periods of remission and relapse (Marcks et al.,
2011; Eisen et al., 2013; Judd et al., 1998) while temporal se-
quencing solely assesses the order of the age of onset of the ﬁrst
episode. In addition, a factor that causes a certain disorder may not
necessarily be the same as the one that leads to relapse, dete-
rioration or chronicity.
Different underlying mechanisms may explain how depressivesymptoms may provoke, maintain, or modulate obsessive-com-
pulsive symptoms in OCD. Depressed patients may have less en-
ergy to resist the compulsions which can maintain the obsessive-
compulsive symptoms and worsen the prognosis. Depressive
cognitions of self-blame, guilt, or catastrophic interpretations may
be applied to the occurrence and the content of the obsessions,
making them more salient and thus increasing the need to carry
out compulsions. Rumination, worries, and doubting are frequent
symptoms in depressive patients and may lead to a heightened
state of anxiety. In people prone to OCD, attempts to reduce this
anxiety may result in an increase in compulsive behavior.
In conclusion, the present study demonstrates a relation be-
tween depressive symptoms and the course of obsessive-com-
pulsive symptoms in OCD patients, irrespective of a current diag-
nosis of MDD and the sequence of onset of OCD and MDD. The
effect of the obsessive-compulsive symptoms on the course of the
depressive symptoms is less clear. Our results did not demonstrate
a signiﬁcant relation between obsessive-compulsive symptoms
and the course of the depressive symptoms, but cannot exclude it.
When the strengths of both directions of the relation between
obsessive-compulsive and depressive symptoms were compared
directly, the difference was not signiﬁcant except in the small
group of participants with comorbid MDD preceding the OCD.
The results suggest a causal relationship between the severity
of depressive symptoms and the course of obsessive-compulsive
symptoms. However, theoretically, there might be other factors
affecting both depressive and obsessive-compulsive symptoms,
such as comorbidity, antidepressant medication or psychotherapy.
No participants were excluded due to comorbidity (in fact more
than half of the participants had at least one comorbid diagnosis).
This was an explicit choice to ensure the generalizability of our
results, as comorbidity is common in OCD. The most frequent
comorbid disorders were MDD and diverse anxiety disorders but
overall, the comorbid diagnoses were quite heterogeneous. It
therefore seems unlikely that they would explain our results.
More than half of the participants were on antidepressant
medication and more than 90% had contacts with a mental health
care professional between baseline and follow-up. Antidepressant
medication and the contacts with mental health care professionals
did not differ between participants with and without MDD.
However, we did not assess the therapeutic interventions and the
reason for the consultations, which is a clear limitation.
Further limitations are the assessment of the obsessive-com-
pulsive symptoms and the deﬁnition of the age of onset. The age of
onset was assessed retrospectively and measured in years. For the
measurement of the obsessive-compulsive symptoms, we used the
clinician-rated version of the Y-BOCS at baseline and the self-re-
port version at follow-up. The follow-up was less extensive than
the baseline assessment and contained only self-report ques-
tionnaires to limit the patients’ study burden. However, the self-
report Y-BOCS is a reliable and valid measure, which shows strong
convergent validity with the interview Y-BOCS (Steketee et al.,
1996).
Another limitation is the possibility of a selection bias. Patients
were recruited from outpatient clinics and treatment programs for
anxiety and obsessive-compulsive disorders. Probably, there were
also patients with both MDD and OCD who were referred to an
outpatient clinic or treatment program for mood disorders, and
hence were not included in the present study. This might explain
the mild to moderate severity of the depressive symptoms and the
prevalence of current MDD being eighteen percent, which is quite
low compared to the literature. On the other hand, the lifetime
prevalence of MDD in our sample was 57%, which is in line with
most of the lifetime prevalence rates reported in the literature
(Quarantini et al., 2011; Pinto et al., 2006; Zitterl et al., 2000;
Marcks et al., 2011).
J. Rickelt et al. / Journal of Affective Disorders 203 (2016) 241–247246Finally, the study had a 31% dropout at follow-up. We dealt
with missing data using an estimation method (FIML) that is ap-
propriate when the missing data are missing at random (MAR).
Estimation or imputation methods could not be applied reliably to
the dropouts for their data is likely not missing at random (non-
ignorable missingness). However, we do not expect that the
missing data affected our results, because the dropouts and com-
pleters did not differ in their clinical characteristics at baseline. In
addition, dropouts were taken into account in the design of the
study (Schuurmans et al., 2012), and even after dropout the ana-
lyses are based on the large sample size of 286 participants.
There are few prospective longitudinal studies that address the
relation between obsessive-compulsive and depressive symptoms
and to our knowledge the present study is the ﬁrst one which
studied a naturalistic course in adult OCD patients. Replication of
the study in other clinical or population-based samples may an-
swer the question whether the results can be generalized to other
groups than OCD patients. Future studies should also focus on
possible factors that mediate the reciprocal inﬂuence of obsessive-
compulsive and depressive symptoms, such as shared vulner-
abilities or common biological mechanisms.
The ﬁndings of the present study have several clinical im-
plications. Considering the high prevalence of lifetime and current
MDD in OCD patients and the inﬂuence of the depressive symp-
toms on the course of the obsessive-compulsive symptoms, de-
pressive symptoms should be routinely assessed in OCD patients.
Our results do not conﬁrm the assumption that in OCD patients
the depressive symptoms improve along with the obsessive-
compulsive symptoms. Instead, depressive symptoms may main-
tain or worsen OCD symptoms. Therefore, we recommend that
treatment also needs to address the depression. There are ex-
amples of treatment programs that combine interventions from
cognitive behavioral therapy for depression and OCD, with positive
results (Abramowitz, 2004; Arco, 2015; Rector et al., 2009). Phar-
macotherapy with serotonergic antidepressants is another treat-
ment option which addresses both disorders and can be combined
with cognitive behavioral therapy for OCD (Romanelli et al., 2014;
Soomro et al., 2008).Acknowledgements
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